Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine D Castle

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Research|August 21, 2019
Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation TherapyKatherine D Castle, David G Kirsch
Translational Cancer Research|February 9, 2019
Genetically engineered mouse models for studying radiation biologyKatherine D Castle, Mark Chen, Amy J Wisdom, et al.
Radiation Research|April 12, 2014
Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in miceChang-Lung Lee, William E Lento, Katherine D Castle, et al.
Radiation Research|April 11, 2018
Mice Lacking RIP3 Kinase are not Protected from Acute Radiation SyndromeKatherine D Castle, Andrea R Daniel, Everett J Moding, et al.
Theranostics|March 21, 2018
Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation TherapyJeffrey R Ashton, Katherine D Castle, Yi Qi, et al.
Cancer Research|October 14, 2018
Deletion of <i>Atm</i> in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung AdenocarcinomaJordan A Torok, Patrick Oh, Katherine D Castle, et al.
JCI Insight|July 26, 2016
An extra copy of <i>p53</i> suppresses development of spontaneous Kras-driven but not radiation-induced cancerEverett J Moding, Hooney D Min, Katherine D Castle, et al.
The Journal of Clinical Investigation|July 19, 2014
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endotheliumEverett J Moding, Chang-Lung Lee, Katherine D Castle, et al.
Nature Communications|September 25, 2015
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphomaChang-Lung Lee, Katherine D Castle, Everett J Moding, et al.
Science Translational Medicine|March 13, 2015
Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapyEverett J Moding, Katherine D Castle, Bradford A Perez, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Research|August 21, 2019
Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation TherapyKatherine D Castle, David G Kirsch
Translational Cancer Research|February 9, 2019
Genetically engineered mouse models for studying radiation biologyKatherine D Castle, Mark Chen, Amy J Wisdom, et al.
Radiation Research|April 12, 2014
Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in miceChang-Lung Lee, William E Lento, Katherine D Castle, et al.
Radiation Research|April 11, 2018
Mice Lacking RIP3 Kinase are not Protected from Acute Radiation SyndromeKatherine D Castle, Andrea R Daniel, Everett J Moding, et al.
Theranostics|March 21, 2018
Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation TherapyJeffrey R Ashton, Katherine D Castle, Yi Qi, et al.
Cancer Research|October 14, 2018
Deletion of <i>Atm</i> in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung AdenocarcinomaJordan A Torok, Patrick Oh, Katherine D Castle, et al.
JCI Insight|July 26, 2016
An extra copy of <i>p53</i> suppresses development of spontaneous Kras-driven but not radiation-induced cancerEverett J Moding, Hooney D Min, Katherine D Castle, et al.
The Journal of Clinical Investigation|July 19, 2014
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endotheliumEverett J Moding, Chang-Lung Lee, Katherine D Castle, et al.
Nature Communications|September 25, 2015
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphomaChang-Lung Lee, Katherine D Castle, Everett J Moding, et al.
Science Translational Medicine|March 13, 2015
Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapyEverett J Moding, Katherine D Castle, Bradford A Perez, et al.
Pageof 2